Discontinuation report PROVERA 10MG TABLETS
| Report ID | 262135 |
| Drug Identification Number | 00729973 |
| Brand name | PROVERA 10MG TABLETS |
| Common or Proper name | Provera 10mg |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Btl 100 |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-10-13 |
| Actual discontinuation date | 2025-09-22 |
| Remaining supply date | 2025-09-22 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-09-24 | French | Compare |
| v5 | 2025-09-24 | English | Compare |
| v4 | 2025-08-19 | French | Compare |
| v3 | 2025-08-19 | English | Compare |
| v2 | 2025-07-07 | French | Compare |
| v1 | 2025-07-07 | English | Compare |
Showing 1 to 6 of 6